Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase subunit B4 pseudogene 12 (NDUFB4P12)

Target
NDUFB4P12
Molecular classification
Pseudogene
01

Overview

**NADH:ubiquinone oxidoreductase subunit B4 pseudogene 12 (NDUFB4P12) is a pseudogene in the human genome and does not encode a functional protein.[1][3]** Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional due to mutations, deletions, or truncations preventing protein expression. This pseudogene is related to the functional gene NDUFB4, which codes for a subunit of mitochondrial Complex I (NADH dehydrogenase), but NDUFB4P12 itself has no known biological function, clinical utility, or role in disease.[1][3][5] Additional clarifying notes: - This entry is *not* a valid therapeutic target as pseudogenes do not encode proteins that could be pharmacologically targeted. - There is no evidence this pseudogene acts as a non-coding RNA, regulatory sequence, or other functional element based on the available sources. Summary: NDUFB4P12, NADH:ubiquinone oxidoreductase subunit B4 pseudogene 12, is a pseudogene with no protein product, no functional role, and no value as a therapeutic target, biomarker, or disease gene[1][3][5].

Other names
NDUFB4P12NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, pseudogene 12NADH:ubiquinone oxidoreductase subunit B4 pseudogene 12[1][3]
02

Mechanism of action

Not applicable (no protein product or known inhibitors/activators)

03

Biological functions

None (pseudogene; does not encode functional protein)[1][3]
04

Disease associations

None (no documented disease association as a functional molecular target)
05

Safety considerations

None (not targeted therapeutically; no protein product)
06

Interacting drugs

None (no functional protein product, not a known drug target)
07

Biomarkers

None (not used as biomarker for patient selection or efficacy monitoring)

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase subunit B4 pseudogene 12 (NDUFB4P12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B4 pseudogene 12 (NDUFB4P12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call